1 / 11

Bioresorbable implants market analysis| Coherent Market Insights

Read here the latest updates on the Bioresorbable implants market analysis published by the CMI team.

Download Presentation

Bioresorbable implants market analysis| Coherent Market Insights

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Coherent Marketing Insights https://www.coherentmarketinsights.com/ Market Research & Business Consulting Services Covid-19 Impact Tracker

  2. BIORESORBABLE IMPLANTS MARKET ANALYSIS Bioresorbable Implants Market - Global Forecast to 2026, by Material Type (Metallic and Polymer), by Application (Orthopedic, Cardiovascular, and Others), by End User (Hospitals, Ambulatory Surgical Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Trends, and Forecast to 2026 Bioresorbable implants play a major role in advance healthcare, as they support and improve damaged biological structure. Bioresorbable implants are biologically integrated into the body, which gradually decomposes after a stipulated time. The global bioresorbable implants market size was valued at US$ 5,543.1 million in 2017, and is expected to exhibit a CAGR of 7.7 % over the forecast period (2018 – 2026).

  3. Figure 1. Global Bioresorbable Implants Market Value (US$ Mn), by Region, 2017

  4. Increasing incidences of orthopedic surgeries is expected to propel growth of the bioresorbable implants market Bioresorbable implants are used in various dental, orthopedic, and other surgeries. Moreover, high prevalence of cardiovascular disease is expected to propel demand for cardiovascular surgeries, which in turn is expected to drive the market growth. According to the World Health Organization (WHO) May 2017, factsheet around 17.9 million people died due to cardiovascular disease in 2016, accounting for 31% of all worldwide deaths. Moreover, increasing incidences of trauma associated with skeletal injuries is propelling growth of the bioresorbable implants market over the forecast period. According to the World Health Organization (WHO) factsheet 2018, road accidents cause around 20 and 50 million injuries annually around the world. Road traffic injuries are the leading cause of death among people aged between 5 and 29 years, and more than 1.35 million people die each year as a result of road traffic crashes globally.

  5. Figure 2. Global Bioresorbable Implants Market Share (%), by Material Type, 2018 and 2026

  6. Increasing research and development in cardiovascular segment in North America is expected to bolster the market growth North America holds dominant position in the global bioresorbable implants market, owing to high prevalence of cardiovascular disease. According to the American Heart Association, 2016, cardiovascular diseases accounted for around 17.3 million deaths annually worldwide, where an estimated 23.3 million people are expected to die from cardiovascular disease by 2030. For instance, Sirolimus-eluting Iron Bioresorbable Coronary Scaffold System developed by Lifetech Scientific (Shenzhen) Co., Ltd. is under study and estimated to complete study in April 2023. Moreover, increase in geriatric population in this region is expected to propel demand for osteoporosis and osteoarthritis cases, which in turn is expected to bolster the market growth over the forecast period. For instance, according to International Osteoporosis Foundation statistics, osteoporosis cause more than 8.9 million fractures annually worldwide, resulting in an osteoporotic fracture every 3 seconds and around 1.6 million hip fractures occur worldwide each year.

  7. Key Players Moreover, key players in the market are focused on receiving the U.S. Food and Drug Administration (FDA) approval for novel products to treat patients. For instance, Boston Scientific, which launched its SYNERGY Bioabsorbable Polymer Drug-Eluting Stent System consist of platinum, chromium metals. This stent is highly accepted amongst physician worldwide because of its optimal healing property and providing treatment option for complex cases. Major players operating in the global bioresorbable implants market include Bioretec Ltd., CONMED Corporation, Depuy Synthes, Stryker Corporation, Zimmer Biomet Holdings, Inc., Smith & Nephew Plc., and Boston Scientific Corporation.

  8. Request Sample Report Request Customization Download PDF Brochure Talk to Analyst Referance: https://www.coherentmarketinsights.com/market-insight/bioresorbable-implants-market-2478

  9. About Us Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. What We Provide:Customized Market Research AnalysisIndustry Analysis ServicesBusiness Consulting ServicesLong Term Engagement ModelCountry Specific Analysis

  10. Contact Us Mr. Shah Coherent Market Insights Pvt. LTD.Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154, U.S.Phone: +1-206-701-6702 Email: sales@coherentmarketinsights.com

  11. Thank You Kindly Follow CMI Social Media Profiles for the latest Company Updates. Facebook Linkedin Twitter https://www.coherentmarketinsights.com/

More Related